Chemical Name: 8-Bromo-1H,4H-[1,2,4]oxadiazolo[3,4-c][1,4]benzoxazin-1-one
Biological ActivityNS 2028 is a potent soluble guanylyl cyclase (sGC) inhibitor (Ki = 8 nM). Blocks sGC activity in murine cerebellum induced by S-nitroso-glutathione and NMDA (IC50 values are 17 and 20 nM respectively). Inhibits VEGF-induced cGMP accumulation; abolishes VEGF-induced migration in postcapillary venular endothelial cells (CVEC).
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Complete Your Research
Synthesis and biological evaluation of oxadiazole derivatives as inhibitors of soluble guanylyl cyclase.
von Wantoch Rekowski et al.
The soluble guanylyl cyclase inhibitor NS-2028 reduces vascular endothelial growth factor-induced angiogenesis and permeability.
Morbidelli et al.
Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
Olesen et al.
No product specific FAQs exist for this product, however you mayView all Small Molecule FAQs
Reviews for NS 2028
There are currently no reviews for this product. Be the first to review NS 2028 and earn rewards!
Have you used NS 2028?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image